- Home
- IPHA vs FT Comparison
IPHA vs FT Comparison
Compare IPHA & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FT
- Stock Information
- Founded
- IPHA 1999
- FT 1988
- Country
- IPHA France
- FT United States
- Employees
- IPHA N/A
- FT N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FT Trusts Except Educational Religious and Charitable
- Sector
- IPHA Health Care
- FT Finance
- Exchange
- IPHA Nasdaq
- FT Nasdaq
- Market Cap
- IPHA 171.6M
- FT 171.4M
- IPO Year
- IPHA 2019
- FT N/A
- Fundamental
- Price
- IPHA $2.25
- FT $7.52
- Analyst Decision
- IPHA Strong Buy
- FT
- Analyst Count
- IPHA 1
- FT 0
- Target Price
- IPHA $11.50
- FT N/A
- AVG Volume (30 Days)
- IPHA 6.4K
- FT 63.0K
- Earning Date
- IPHA 09-12-2024
- FT 01-01-0001
- Dividend Yield
- IPHA N/A
- FT 7.85%
- EPS Growth
- IPHA N/A
- FT N/A
- EPS
- IPHA N/A
- FT N/A
- Revenue
- IPHA $36,202,722.00
- FT N/A
- Revenue This Year
- IPHA N/A
- FT N/A
- Revenue Next Year
- IPHA $105.84
- FT N/A
- P/E Ratio
- IPHA N/A
- FT N/A
- Revenue Growth
- IPHA N/A
- FT N/A
- 52 Week Low
- IPHA $1.81
- FT $5.97
- 52 Week High
- IPHA $3.15
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- IPHA 49.51
- FT 79.01
- Support Level
- IPHA $2.22
- FT $7.31
- Resistance Level
- IPHA $2.29
- FT $7.33
- Average True Range (ATR)
- IPHA 0.13
- FT 0.06
- MACD
- IPHA -0.01
- FT 0.01
- Stochastic Oscillator
- IPHA 48.09
- FT 84.87
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.